[
    [
        {
            "time": "",
            "original_text": "安徽区域股市周报：欧普康视跌19.23%跌幅第一 2亿融资买入阳光电源",
            "features": {
                "keywords": [
                    "欧普康视",
                    "跌幅",
                    "融资买入",
                    "阳光电源"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "新能源"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "安徽区域股市周报：欧普康视跌19.23%跌幅第一 2亿融资买入阳光电源",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 9,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业周报：疫苗加强针接种工作陆续开启 关注三季报业绩预期差投资机会",
            "features": {
                "keywords": [
                    "医药生物",
                    "疫苗",
                    "加强针",
                    "三季报",
                    "业绩预期"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业周报：疫苗加强针接种工作陆续开启 关注三季报业绩预期差投资机会",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 1,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "欧普康视董秘回复：限二级以上医院验配塑形镜二十年前就发布 不影响公司",
            "features": {
                "keywords": [
                    "欧普康视",
                    "董秘回复",
                    "政策限制",
                    "塑形镜"
                ],
                "sentiment_score": 0.2,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "欧普康视董秘回复：限二级以上医院验配塑形镜二十年前就发布 不影响公司",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "欧普康视：公司在北京是通过经销商销售，没有自营的验配中心",
            "features": {
                "keywords": [
                    "欧普康视",
                    "经销商",
                    "自营",
                    "验配中心"
                ],
                "sentiment_score": 0.1,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "欧普康视：公司在北京是通过经销商销售，没有自营的验配中心",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 4,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "欧普康视：公司直销的都是符合政策的",
            "features": {
                "keywords": [
                    "欧普康视",
                    "直销",
                    "政策"
                ],
                "sentiment_score": 0.3,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "欧普康视：公司直销的都是符合政策的",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 4,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业跨市场周报：三季报业绩期来临 关注业绩与估值匹配的核心赛道",
            "features": {
                "keywords": [
                    "医药生物",
                    "三季报",
                    "业绩",
                    "估值",
                    "核心赛道"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业跨市场周报：三季报业绩期来临 关注业绩与估值匹配的核心赛道",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 1,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业：创新药国谈价格前瞻分析",
            "features": {
                "keywords": [
                    "医药生物",
                    "创新药",
                    "国谈",
                    "价格前瞻"
                ],
                "sentiment_score": 0.4,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业：创新药国谈价格前瞻分析",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 1,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]